|
Volumn 17 Suppl B, Issue , 2003, Pages
|
How can the current strategies for Helicobacter pylori eradication therapy be improved?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
AMOXICILLIN;
ANTIINFECTIVE AGENT;
ANTIULCER AGENT;
CLARITHROMYCIN;
DRUG DERIVATIVE;
LANSOPRAZOLE;
OMEPRAZOLE;
PROTON PUMP;
ARTICLE;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG COMBINATION;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
META ANALYSIS;
TIME;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
AMOXICILLIN;
ANTI-BACTERIAL AGENTS;
ANTI-ULCER AGENTS;
CLARITHROMYCIN;
DRUG THERAPY, COMBINATION;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
OMEPRAZOLE;
PROTON PUMPS;
TIME FACTORS;
MLCS;
MLOWN;
|
EID: 2142640385
PISSN: 08357900
EISSN: None
Source Type: Journal
DOI: 10.1155/2003/714124 Document Type: Article |
Times cited : (90)
|
References (0)
|